Skip to main content

Published locations for Model: Quadrivalent vaccine could cost effectively cut MSM’s HPV-related cancers

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Model: Quadrivalent vaccine could cost effectively cut MSM’s HPV-related cancers

User login

  • Reset your password
  • /content/model-quadrivalent-vaccine-could-cost-effectively-cut-msms-hpv-related-cancers
  • /edermatologynews/article/130729/sexual-health/model-quadrivalent-vaccine-could-cost-effectively-cut
  • /familypracticenews/article/130729/sexual-health/model-quadrivalent-vaccine-could-cost-effectively
  • /idpractitioner/article/130729/sexual-health/model-quadrivalent-vaccine-could-cost-effectively-cut
  • /internalmedicinenews/article/130729/sexual-health/model-quadrivalent-vaccine-could-cost-effectively
  • /infectiousdisease/article/130729/sexual-health/model-quadrivalent-vaccine-could-cost-effectively-cut
  • /internalmedicine/article/130729/sexual-health/model-quadrivalent-vaccine-could-cost-effectively-cut
  • /dermatology/article/130729/sexual-health/model-quadrivalent-vaccine-could-cost-effectively-cut-msms
  • /familymedicine/article/130729/sexual-health/model-quadrivalent-vaccine-could-cost-effectively-cut